Maria Jose Frutos

TL;DR: There is evidence from interventional clinical trials that intake of doses equal or above 800 mg EGCG/day taken as a food supplement has been shown to induce a statistically significant increase of serum transaminases in treated subjects compared to control.

TL;DR: The EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) provides a scientific opinion re‐evaluating the safety of silicon dioxide (E 551) when used as a food additive, concluding that the EU specifications are insufficient to adequately characterise the food additive E 551.

TL;DR: The Panel concluded that an increased methaemoglobin level, observed in human and animals, was a relevant effect for the derivation of the ADI and estimated the MoE to exogenous nitrosamines in meat products to be < 10,000 in all age groups at high level exposure.

TL;DR: The Panel concluded that currently there was insufficient evidence to withdraw this ADI and that even using the highest nitrate‐to‐nitrite conversion factor the methaemoglobin levels produced due to nitrite obtained from this conversion would not be clinically significant and would result to a theoretically estimated endogenous N‐nitroso compounds (ENOC) production at levels which would be of low concern.

TL;DR: The Panel concluded that the existing group acceptable daily intake (ADI) for carrageenan and processed Eucheuma seaweed (E 407a) of 75 mg/kg bw per day should be considered temporary, while the database should be improved within 5 years after publication of this opinion.